Semaglutide Shows Major Benefits in PAD: STRIDE
The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a practice-changing trial, according to experts.
Medscape Medical News
source https://www.medscape.com/viewarticle/semaglutide-shows-major-benefits-peripheral-arterial-disease-2025a10007kp?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/semaglutide-shows-major-benefits-peripheral-arterial-disease-2025a10007kp?src=rss
Comments
Post a Comment